4th Quarter - Report
THE MCMANUS GROUP for EMD SERONO, INC.
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
General pharmaceutical coverage and reimbursement issues, issues and activities affecting oncology, neurodegenerative and fertility products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAWREN D GEER | — |
| JOHN MCMANUS | — |
| ALANNA TEMME | LD, Rep. Jon Porter |
Medicare/Medicaid MMM
Medicare and Medicaid pharmaceutical coverage and reimbursement issues, particularly regarding neurodegenerative products. Provisions included in Title I-Subtitle B of PL. 177-169/H.R. 5376 - Inflation Reduction Act of 2022.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAWREN D GEER | — |
| JOHN MCMANUS | — |
| ALANNA TEMME | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.